ClinicalTrials.gov
ClinicalTrials.gov Menu

MRI Superficial Temporal Artery

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00188448
Recruitment Status : Completed
First Posted : September 16, 2005
Last Update Posted : April 23, 2007
Sponsor:
Information provided by:
University Health Network, Toronto

Brief Summary:
Repeat MRI of the Superficial temporal Artery in 5 volunteers

Condition or disease Intervention/treatment Phase
Temporal Arteritis Device: MRI Phase 1

Detailed Description:
Repeat MRI of the Superficial temporal Artery in 5 volunteers

Study Type : Interventional  (Clinical Trial)
Enrollment : 5 participants
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: MRI of the Superficial Temporal Artery
Study Start Date : April 2003
Study Completion Date : April 2004

Resource links provided by the National Library of Medicine

U.S. FDA Resources




Primary Outcome Measures :
  1. Accuracy in displaying the superfifical temporal artery


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   16 Years and older   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • controls with normal temporal arteries

Exclusion Criteria:

  • contraindication to MR

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00188448


Locations
Canada, Ontario
Toronto General Hospital
Toronto, Ontario, Canada
Sponsors and Collaborators
University Health Network, Toronto
Investigators
Principal Investigator: Narinder Paul, FRCP C University Health Network, Toronto

ClinicalTrials.gov Identifier: NCT00188448     History of Changes
Other Study ID Numbers: 03-0223
First Posted: September 16, 2005    Key Record Dates
Last Update Posted: April 23, 2007
Last Verified: September 2005

Additional relevant MeSH terms:
Arteritis
Giant Cell Arteritis
Vasculitis
Vascular Diseases
Cardiovascular Diseases
Vasculitis, Central Nervous System
Autoimmune Diseases of the Nervous System
Nervous System Diseases
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Skin Diseases, Vascular
Skin Diseases
Autoimmune Diseases
Immune System Diseases